Latest Sustainability News

Investore Property Limited reported a resilient FY26 with 14% portfolio growth driven by acquisitions, maintained dividends, and proactive capital management amid inflationary pressures.

HyTerra Ltd has issued 290 million shares through a non-renounceable rights issue, raising $4.07 million, falling short of its $7 million target and leaving a sizeable shortfall of over 209 million shares.

Ballard Mining's March quarter update reveals a robust 1.2 million ounce gold resource at Mt Ida and a healthy $75.6 million cash position, setting the stage for a Final Investment Decision in H1 2027.

Gold Hydrogen is accelerating Helium development at its Ramsay Project, leveraging exceptional purity results and independent modelling amid a tightening global Helium supply.

Flagship Minerals has secured A$2.75 million through a strategic placement led by long-term partners, poised to accelerate feasibility and technical work at its 2.1 million ounce Isidora Gold Project in Chile.

RAS Technology Holdings has locked in new contracts and extensions expected to add at least $2 million in annualised revenue, reinforcing growth in wagering technology and international markets.

MyEco Group has extended its partnership with Penrith City Council by winning a 3-to-5-year contract to supply compostable caddy liners for the council's FOGO program, aligning with NSW's mandated organics recycling rollout.

Ex-CEO Geoff Cockerill has initiated court proceedings against Vitura Limited, alleging breaches of the Fair Work Act related to his January 2026 departure. Vitura maintains all contractual obligations were met and plans to resolve the dispute swiftly.

Close the Loop Limited has sold its ISP Tek Services business for US$10 million, slashed US$16 million of debt, and set an optimistic EBITDA target of $14 million to $16 million for FY27, signalling a sharper focus on its packaging and resource recovery strengths.

Thrive Tribe Technologies (ASX:1TT) is issuing approximately 116.87 million Loyalty Options to shareholders at no cost, exercisable at $0.003 each and expiring in 2029, aiming to reward loyalty and potentially raise capital upon exercise.

Cleo Diagnostics has laid out a clear U.S. reimbursement pathway for its ovarian cancer test, leveraging an existing CPT code to enable early market entry and data collection ahead of FDA clearance.

IMEXHS Limited exceeded FY25 revenue and EBITDA guidance, driven by strategic contract wins and AI-powered workflow automation. The company projects stronger software growth and sustained profitability in FY26.